Expression of cyclooxygenase and lipoxygenase enzymes in nasal polyps of aspirin-sensitive and aspirin-tolerant patients

Archives of Otolaryngology - Head and Neck Surgery

Volumn 132, Issue 6, 2006, Pages 579-587

  Owens, Jonathan M ^a   Shroyer, Kenneth R ^a   Kingdom, Todd T ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ARACHIDONATE 12 LIPOXYGENASE; ARACHIDONATE 15 LIPOXYGENASE; ARACHIDONATE 5 LIPOXYGENASE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; LIPOXYGENASE; PROSTAGLANDIN SYNTHASE;

ARTICLE; BASAL CELL; CELL MEMBRANE; CLINICAL ARTICLE; COLUMNAR EPITHELIUM; CONTROLLED STUDY; CYTOPLASM; DRUG SENSITIVITY; DRUG TOLERABILITY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MUCUS GLAND; NOSE POLYP; PROTEIN EXPRESSION; RHINOSINUSITIS; STAINING;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; CASE-CONTROL STUDIES; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; HUMANS; IMMUNOHISTOCHEMISTRY; LIPOXYGENASE; NASAL POLYPS; RHINITIS; STATISTICS, NONPARAMETRIC;

EID: 33745272856     PISSN: 08864470     EISSN: 08864470     Source Type: Journal    
DOI: 10.1001/archotol.132.6.579     Document Type: Article

References (31)

1. Pujols L, Mullol J, Alobid I, Roca-Ferrer J, Xaubet A, Picado C. Dynamics of COX-2 in nasal mucosa and nasal polyps from aspirin-tolerant and aspirin-intolerant patients with asthma. J Allergy Clin Immunol. 2004;114:814-819.
2. Babu KS, Salvi SS. Aspirin and asthma. Chest. 2000;118:1470-1476.
3. Mullol J, Fernandez-Morata JC, Roca-Ferrer J, et al. Cyclooxygenase 1 and cyclooxygenase 2 expression is abnormally regulated in human nasal polyps. J Allergy Clin Immunol. 2002;109:824-830.
4. Yun CB, Lee BH, Jang TJ. Expression of glucocorticoid receptors and cyclooxygenase-2 in nasal polyps from nonallergic patients. Ann Otol Rhinol Laryngol. 2002;111:61-67.
5. Demoly P, Crampette L, Lebel B, Campbell AM, Mondain M, Bousquet J. Expression of cyclo-oxygenase 1 and 2 proteins in upper respiratory mucosa. Clin Exp Allergy. 1998;28:278-283.
6. Seymour ML, Rak S, Aberg D, et al. Leukotriene and prostanoid pathway enzymes in bronchial biopsies of seasonal allergic asthmatics. Am J Respir Crit Care Med. 2001;164:2051-2056.
7. Chu HW, Balzar S, Westcott JY, et al. Expression and activation of 15-lipoxygenase pathway in severe asthma: relationship to eosinophilic phenotype and collagen deposition. Clin Exp Allergy. 2002;32:1558-1565.
8. Gosepath J, Brieger J, Mann WJ. New immunohistologic findings on the differential role of cyclooxygenase 1 and cyclooxygenase 2 in nasal polyposis. Am J Rhinol. 2005;19:111-116.
9. Fernandez-Morata JC, Mullol J, Fuentes M, et al. Regulation of cyclooxygenase-1 and -2 expression in human nasal mucosa: effects of cytokines and dexamethasone. Clin Exp Allergy. 2000;30:1275-1284.
10. Demoly P, Jaffuel D, Lequeux N, et al. Prostaglandin H synthase 1 and 2 immunoreactivities in the bronchial mucosa of asthmatics. Am J Respir Crit Care Med. 1997;155:670-675.
11. Sousa A, Pfister R, Christie PE, et al. Enhanced expression of cyclo-oxygenase isoenzyme 2 (COX-2) in asthmatic airways and its cellular distribution in aspirin-sensitive asthma. Thorax. 1997;52:940-945.
12. Redington AE, Meng QH, Springall DR, et al. Increased expression of inducible nitric oxide synthase and cyclo-oxygenase-2 in the airway epithelium of asthmatic subjects and regulation by corticosteroid treatment. Thorax. 2001;56:351-357.
13. Taha R, Olivenstein R, Utsumi T, et al. Prostaglandin H synthase 2 expression in airway cells from patients with asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2000;161:636-640.
14. Perez-Novo CA, Watelet JB, Claeys C, Van Cauwenberge P, Bacjert C. Prostaglandin, leukotriene, and lipoxin balance in chronic rhinosinusitis with and without nasal polyposis. J Allergy Clin Immunol. 2005;115:1189-1196.
15. Steinke JW, Bradley D, Arango P, et al. Cysteinyl leukotriene expression in chronic hyperplastic sinusitis-nasal polyposis: importance to eosinophilia and asthma. J Allergy Clin Immunol. 2003;111:342-349.
16. Arango P, Borish L, Frierson HF Jr, Kountakis SE. Cysteinyl leukotrienes in chronic hyperplastic rhinosinusitis. Otolaryngol Head Neck Surg. 2002;127:512-515.
17. Corrigan C, Mallett K, Ying S, et al. Expression of the cysteinyl leukotriene receptors cysLT(1) and cysLT(2) in aspirin-sensitive and aspirin-tolerant chronic rhinosinusitis. J Allergy Clin Immunol. 2005;115:316-322.
18. Peters-Golden M. Cell biology of the 5-lipoxygenase pathway. Am J Respir Crit Care Med. 1998;157:S227-S232.
19. Parnes SM. The role of leukotriene inhibitors in patients with paranasal sinus disease. Curr Opin Otolaryngol Head Neck Surg. 2003;11:184-191.
20. Misson J, Clark W, Kendall MJ. Therapeutic advances: leukotriene antagonists for the treatment of asthma. J Clin Pharm Ther. 1999;24:17-22.
21. McMillan RM. Leukotrienes in respiratory disease. Paediatr Respir Rev. 2001;2:238-244.
22. Kuhn H, Walther M, Kuban RJ. Mammalian arachidonate 15-lipoxygenases: structure, function, and biologic activity. Prostaglandins Other Lipid Mediat. 2002;68-69:263-290.
23. Bonnans C, Chanez P, Chaivs C. Lipoxins in asthma: potential therapeutic mediators on bronchial inflammation? Allergy. 2004;59:1027-1041.
24. Jung TT. Prostaglandins, leukotrienes, and other arachidonic acid metabolites in the pathogenesis of otitis media. Laryngoscope. 1988;98:980-993.
25. De Marzo N, Sloane DL, Dicharry S, Highland E, Sigal E. Cloning and expression of an airway epithelial 12-lipoxygenase. Am J Physiol. 1992;262:L198-L207.
26. Yoshimoto T, Takahashi Y. Arachidonate 12-lipoxygenases. Prostaglandins Other Lipid Mediat. 2002;68-69:245-262.
27. Yoshimura R, Inoue K, Kawahito Y, et al. Expression of 12-lipoxygenase in human renal cell carcinoma and growth prevention by its inhibitor. Int J Mol Med. 2004;13:41-46.
28. Wang H, Li J, Follett PL, et al. 12-Lipoxygenase plays a key role in cell death caused by glutathione depletion and arachidonic acid in rat oligodendrocytes. Eur J Neurosci. 2004;20:2049-2058.
29. Gillis RC, Daley BJ, Enderson BL, Karlstad MD. Role of downstream metabolic processing of proinflammatory fatty acids by 5-lipoxygenase in HL-60 cell apoptosis. J Trauma. 2003;54:91-103.
30. Heydeck D, Thomas L, Schnurr K, et al. Interleukin-4 and -13 induce upregulation of the murin macrophage 12/15-lipoxygenase activity: evidence for the involvement of transcription factor STAT6. Blood. 1998;92:2503-2510.
31. Han X, Chen S, Sun Y, Nadler JL, Bleich D. Induction of cyclooxygenase-2 gene in pancreatic beta-cells by 12-lipoxygenase pathway product 12-hydroxyeicosatetraenoic acid. Mol Endocrinol. 2002;16:2145-2154.